Cargando…
Serum concentration–guided intravenous magnesium sulfate administration for neuroprotection in patients with aneurysmal subarachnoid hemorrhage: a retrospective evaluation of a 12-year single-center experience
Delayed cerebral infarction (DCI) is a major cause of morbidity and mortality in patients with aneurysmal subarachnoid hemorrhage (aSAH). The benefits of magnesium sulfate as an alternative treatment are controversial, and most previous studies examined its benefits only as adjunctive treatment to t...
Autores principales: | Wipplinger, C., Cattaneo, A., Wipplinger, T. M., Lamllari, K., Semmler, F., Geske, C., Messinger, J., Nickl, V., Beez, A., Ernestus, R.-I., Pham, M., Westermaier, T., Weiland, J., Stetter, C., Kunze, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522732/ https://www.ncbi.nlm.nih.gov/pubmed/37751032 http://dx.doi.org/10.1007/s10143-023-02159-1 |
Ejemplares similares
-
Investigating the relationship between high-dose norepinephrine administration and the incidence of delayed cerebral infarction in patients with aneurysmal subarachnoid hemorrhage: A single-center retrospective evaluation
por: Cattaneo, Andrea, et al.
Publicado: (2023) -
Neuroprotective Strategies in Aneurysmal Subarachnoid Hemorrhage (aSAH)
por: Weiland, Judith, et al.
Publicado: (2021) -
Magnesium treatment for neuroprotection in ischemic diseases of the brain
por: Westermaier, Thomas, et al.
Publicado: (2013) -
Magnesium Protects in Episodes of Critical Perfusion after Aneurysmal SAH
por: Kunze, Ekkehard, et al.
Publicado: (2018) -
Therapeutic hypercapnia for prevention of secondary ischemia after severe subarachnoid hemorrhage: physiological responses to continuous hypercapnia
por: Stetter, Christian, et al.
Publicado: (2021)